AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Caranx Medical’s AI TAVI-TAVR software gains FDA approval, signaling deeper AI entry into structural heart care
Caranx Medical has won FDA approval for its AI software supporting TAVI-TAVR procedures. The clearance points to growing confidence in procedural AI, where tools can assist planning and execution in high-stakes cardiovascular care.
FDA Approval Gives Caranx Medical a Shot at Redefining AI for Structural Heart Procedures
Caranx Medical’s AI TAVI-TAVR software has won FDA approval, adding momentum to the use of AI in structural heart interventions. The clearance highlights how software is moving closer to the procedural core of cardiovascular care.
FDA Clears a New Transseptal Puncture Device, Targeting a High-Stakes Cardiology Procedure
Protaryx Medical has secured FDA clearance for a transseptal puncture device used in a highly specialized cardiac procedure. The approval matters because devices that reduce procedural complexity can influence both safety and how quickly minimally invasive cardiology techniques spread.
FDA Clears Protaryx’s Transseptal Puncture Device, Adding Momentum in Structural Heart
Protaryx has won FDA clearance for a transseptal puncture device, a procedural tool that could matter in structural heart interventions. While not as headline-grabbing as AI, this approval reflects steady innovation in core cardiovascular tooling.
FDA Clears Protaryx Medical’s Transseptal Device, Targeting Easier Left-Heart Access
The FDA has cleared Protaryx Medical’s transseptal device, designed to improve access to the left side of the heart. The clearance could matter for structural heart and electrophysiology procedures where faster, more controlled access can influence both efficiency and safety.
TRiCares Wins FDA IDE for Pivotal Trial of Tricuspid Regurgitation Device
TRiCares has received FDA approval to begin an investigational device exemption pivotal trial for its tricuspid regurgitation treatment. The move brings another structural-heart therapy closer to the evidence base needed for commercialization and reimbursement.
Philips’ FDA Clearance Shows AI Is Becoming Native to Interventional Cardiology
Philips has won FDA clearance for AI-enabled guidance software in heart valve repair, underscoring a shift from image interpretation AI to procedure-embedded intelligence. The bigger story is that AI is moving into the cath lab and hybrid OR as a live navigation layer rather than a retrospective analytic tool.
FDA clearance for mitral valve repair AI shows where procedural imaging can win
A newly cleared AI tool for mitral valve repair highlights a practical regulatory path for medical AI: narrow, procedure-specific software tied to high-value clinical decisions. The development reinforces that some of the strongest near-term opportunities for AI are in image-guided intervention rather than broad autonomous diagnosis.
FDA clearance for Philips valve-repair guidance shows where imaging AI can win first
Philips says the FDA has cleared an AI solution that provides real-time guidance during complex minimally invasive heart valve repair. The approval highlights a commercially important direction for medical AI: narrow, procedural tools that augment specialist workflows at the point of care.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.